with Joe Wojcik, Senior Director, Pharmaceutical Development Services
Pharma expert, Joe Wojcik, discusses the technical factors and requirements that make BFS an “advanced aseptic process” for fill-finish, and why BFS offers operational efficiencies and has relatively low capital requirements.